Animalcare Group has confirmed that, at the General Meeting held today, all resolutions in connection with the the proposed share placing and the acquisition of Ecuphar NV were passed.
The acquisition and placing are expected to complete tomorrow.
In aggregate, 38,691,790 New Ordinary Shares have been allotted and issued pursuant to the Proposals, comprising 8,571,428 New Placing Shares, 1,368,896 Option Shares and 28,751,466 Consideration Shares.
At 1:22pm: (LON:ANCR) Animalcare Group PLC share price was +2.5p at 357.5p
Animalcare Group has agreed to acquire Ecuphar NV, a European animal health company focused on the development and sale of veterinary pharmaceutical products.
The acquisition constitutes a reverse takeover under AIM Rules and is conditional upon shareholder approval.
Animalcare said the consideration for the acquisition was structured on a consolidated Animalcare/Ecuphar enlarged issued share capital ratio of 37:63 (after taking into account dilution from certain Animalcare incentive arrangements).
It said this would be satisfied through the issue of consideration shares and cash to the Ecu